novartis glp-1 receptor agonist weight management diabetes treatments Optimizing therapies for obesity and GLP-1-based therapies for diabetes, obesity
Description
A systematic search of PubMed, Scopus, and Web of Science was conducted up to December 2024 according to PRISMA guidelines
Indias pharma industry is strong
Adolescents with obesity prescribed a GLP-1 receptor agonist are less likely to have suicidal ideation or a suicide attempt than those with obesity treated with lifestyle intervention, according to new data
Thats why the FDA gives it a boxed warning
Compare every GLP-1 drug for weight loss, see clinical results, and find out which is right for you.
